Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 451 AL 465

From patient cells to patient therapy: Twenty years of iPSC-based translation in neurodegenerative disease

Cha Y, Kim KS.

Cell Rep Med. 2026 Oct 20;7(10):103104. doi: 10.1016/j.xcrm.2026.103104. Epub 2026 Oct 2.

REST in the Central Nervous System: Context-Dependent Regulation of Neuronal Homeostasis and Disease

Carvalho LB, Yamada AK, Furtado LA, Feltran GDS, de Lima ER, Paiva A, Canineo D, Bernardi MM, Fernandes CJDC, da Silva RAF.

Int J Dev Neurosci. 2026 Oct;86(6):e70186. doi: 10.1002/jdn.70186.

Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain

Al-Jehani H, Al-Kuraishy HM, Abdelaziz AM, Mohamed AA, Mamdoh AM, Musa A, Mursy OMA, Batiha GE.

Mol Cell Neurosci. 2026 Oct 5;139:104128. doi: 10.1016/j.mcn.2026.104128. Online ahead of print.

Monitoring huntingtin aggregation in Huntington's disease: methods, challenges and future opportunities

Peeters CIJ, Spits M, Reits EAJ, Schipper-Krom S.

Expert Rev Proteomics. 2026 Oct;23(10):283-299. doi: 10.1080/14789450.2026.2741175. Epub 2026 Oct 29.

Extracellular Vesicles and Exosomes as Biomarkers in Huntington's Disease: Uncovering Pathogenic Insights and Pioneering Therapies

Vafadar A, Shaghaghian D, Charami H, Hadinia F, Didehdar D, Movahedpour A, Ehtiati S.

Mol Neurobiol. 2026 Oct 7;63(1):951. doi: 10.1007/s12035-026-06205-z.

Directing mutant huntingtin towards degradation: Strategies and therapeutic opportunities

Wavreil FD, Schipper-Krom S, Reits EA.

J Huntingtons Dis. 2026 Oct 9:18796397261494078. doi: 10.1177/18796397261494078. Online ahead of print.

Depletion of border-associated macrophages impairs CSF flow and exacerbates extranuclear mutant Huntingtin aggregation in the zQ175DN mouse model of Huntington's disease

Jiang Y, Sondawle R, Moniz H, Mu E, Duan W.

bioRxiv [Preprint]. 2026 Oct 20:2026.09.24.754172. doi: 10.64898/2026.09.24.754172.

Alignment with sex-typical brain architecture: Links to mood pathology, sex hormones and transcriptomics of neurodegenerative conditions

Petrican R, Fornito A.

bioRxiv [Preprint]. 2026 Oct 2:2026.09.27.754773. doi: 10.64898/2026.09.27.754773.

Effect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD

Halabi N, Killoran A, Nopoulos PC.

medRxiv [Preprint]. 2026 Sep 28:2026.09.26.26364085. doi: 10.64898/2026.09.26.26364085.

A New Soaking Protocol to Live Stain C. elegans with Proteostat Dye Reveals Global Patterns of Stress-Induced Protein Aggregation

Krishingner T, Fausett SR.

bioRxiv [Preprint]. 2026 Oct 1:2026.09.30.755777. doi: 10.64898/2026.09.30.755777.

Carbon dot-based nanomaterials in neurodegeneration: addressing neurobiological barriers and targeting challenges

Unnikrishnan B, Anand A, Fang CN, Wu SM, Wang CC, Huang CC, Chu HW, Chang HT.

Chem Commun (Camb). 2026 Oct 12. doi: 10.1039/d6cc03262a. Online ahead of print.

CRISPR/Cas9-based nanodelivery systems for precision gene editing in neuroinflammation

Sahu S, Jain P, Dharme KK, Yadav K.

Inflamm Res. 2026 Oct 12;75(1):237. doi: 10.1007/s00011-026-02383-7.

Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies

Long Z, Guo H, Sun L.

Front Immunol. 2026 Sep 28;17:1965598. doi: 10.3389/fimmu.2026.1965598. eCollection 2026.

HMGB1 functional plasticity in neurodegenerative diseases and its translational implications

Cai W, Yi Y, Zeng R, Yin Y, Zhao J, Zhang J, Fu G, Xu H.

Front Immunol. 2026 Sep 29;17:1928641. doi: 10.3389/fimmu.2026.1928641. eCollection 2026.

The small giant actor in the pathogenesis of neurodegenerative diseases: Microtubules

Gündoğdu AA, Özkan NG, Adapınar DÖ.

Metab Brain Dis. 2026 Oct 14;41(1):235. doi: 10.1007/s11011-026-02001-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias